# Genoptix

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/genoptix

- Industry: Healthcare Specialists
- Headquarters: Carlsbad, US
- Website: www.genoptix.com
- Total disclosed funding: $34M
- Latest round: Series D (Aug 10, 2005)
- Investors on record: 6

## About

Genoptix is a specialized laboratory that provides diagnostic testing services for oncology, utilizing advanced technology to deliver accurate and timely results to healthcare providers.Founded in 1999, Genoptix operates from its headquarters in Carlsbad, California, US. The company focuses on providing diagnostic services in oncology. It has engaged in three deals, with the most recent being an IPO in October 2007, raising USD 85 mn by selling 5 million shares at USD 17 per share.Genoptix specializes in providing innovative diagnostic testing solutions for oncology. Its core offerings include comprehensive laboratory services that enhance patient care through precise and timely test results. The company serves a diverse clientele, primarily consisting of healthcare institutions across North America, and is focused on optimizing cancer diagnostics to improve treatment decisions.In 2009, Genoptix reported a revenue of USD 184.38 mn, with an EBITDA of USD 58.41 mn, reflecting its robust financial performance in the diagnostic services sector.Genoptix aims to expand its product line by developing new diagnostic tests and enhancing its laboratory capabilities. The recent funding from the IPO will be utilized to support these product innovations and to expand its market reach within North America, targeting additional partnerships with healthcare providers by the end of 2010. Through strategic investments, Genoptix seeks to position itself for sustained growth in the oncology diagnostics market.

## Funding rounds

- Series D, Aug 10, 2005, $17M — Enterprise Partners Venture Capital, Tullis Health Investors, Chicago Growth Partners, Alliance Technology Ventures, Lotus Biosciences Ventures
- Series B, Jan 28, 2002, $17M — Enterprise Partners Venture Capital, Tullis Health Investors, Alliance Technology Ventures, Mitsubishi Corporation, Lotus Biosciences Ventures

## Investors

- Enterprise Partners Venture Capital (https://capitalatlas.ai/funds/enterprise-partners-venture-capital) — Series B, Series D
- Tullis Health Investors (https://capitalatlas.ai/funds/tullis-health-investors) — Series B, Series D
- Alliance Technology Ventures (https://capitalatlas.ai/funds/alliance-technology-ventures) — Series B, Series D
- Mitsubishi Corporation — Series B
- Lotus Biosciences Ventures (https://capitalatlas.ai/funds/lotus-biosciences-ventures) — Series B, Series D
- Chicago Growth Partners (https://capitalatlas.ai/funds/chicago-growth-partners) — Series D